Prolonged molecular control during intermittent reduced‐intensity blinatumomab maintenance in a transplant‐ineligible patient with Philadelphia chromosome‐positive acute lymphoblastic leukaemia and IKZF1 deletion

Xiaoqian Duan, Jinjun Yang, Yufei Yang, Shuwen Guo, Yu Wu · 2026

Read Prolonged molecular control during intermittent reduced‐intensity blinatumomab maintenance in a transplant‐ineligible patient with Philadelphia chromosome‐positive acute lymphoblastic leukaemia and IKZF1 deletion by Xiaoqian Duan, Jinjun Yang, Yufei Yang, Shuwen Guo, Yu Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13594394.txt.

Description

Xiaoqian Duan and co-authors report a 64-year-old man with high-risk Philadelphia chromosome-positive acute lymphoblastic leukemia. He could not undergo a stem cell transplant. Yet he stayed in remission for over three and a half years on an unusual maintenance plan. His leukemia carried a gene deletion linked to relapse and had already returned once during targeted drug treatment.

One intensive cycle of the immune engager blinatumomab combined with dasatinib drove the disease to a deep molecular remission. He then switched to brief monthly outpatient infusions of the same antibody at reduced intensity. Daily dasatinib and regular interferon injections completed the plan. Leukemia transcripts stayed undetectable for nearly three years, with only one brief low-level blip that settled without escalation. He had no unplanned hospital stays and no severe nerve side effects, suggesting gentler intermittent dosing can hold this disease while sparing the patient.

Catalog record

CREATORXiaoqian Duan, Jinjun Yang, Yufei Yang, Shuwen Guo, Yu Wu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13594394

Browse the full library · About the Tower of Babel